- Home
- OCCI vs HBIO Comparison
OCCI vs HBIO Comparison
Compare OCCI & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCCI
- HBIO
- Stock Information
- Founded
- OCCI N/A
- HBIO 1901
- Country
- OCCI United States
- HBIO United States
- Employees
- OCCI N/A
- HBIO N/A
- Industry
- OCCI Trusts Except Educational Religious and Charitable
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- OCCI Finance
- HBIO Industrials
- Exchange
- OCCI Nasdaq
- HBIO Nasdaq
- Market Cap
- OCCI 123.6M
- HBIO 117.7M
- IPO Year
- OCCI N/A
- HBIO 2000
- Fundamental
- Price
- OCCI $7.43
- HBIO $2.40
- Analyst Decision
- OCCI
- HBIO
- Analyst Count
- OCCI 0
- HBIO 0
- Target Price
- OCCI N/A
- HBIO N/A
- AVG Volume (30 Days)
- OCCI 115.8K
- HBIO 110.4K
- Earning Date
- OCCI 12-11-2023
- HBIO 11-05-2024
- Dividend Yield
- OCCI 24.32%
- HBIO N/A
- EPS Growth
- OCCI N/A
- HBIO N/A
- EPS
- OCCI N/A
- HBIO N/A
- Revenue
- OCCI N/A
- HBIO $101,125,000.00
- Revenue This Year
- OCCI N/A
- HBIO N/A
- Revenue Next Year
- OCCI $10.19
- HBIO $2.68
- P/E Ratio
- OCCI N/A
- HBIO N/A
- Revenue Growth
- OCCI N/A
- HBIO N/A
- 52 Week Low
- OCCI $5.47
- HBIO $2.39
- 52 Week High
- OCCI $10.15
- HBIO $5.56
- Technical
- Relative Strength Index (RSI)
- OCCI 49.27
- HBIO 32.33
- Support Level
- OCCI $7.34
- HBIO $2.50
- Resistance Level
- OCCI $7.46
- HBIO $2.78
- Average True Range (ATR)
- OCCI 0.12
- HBIO 0.14
- MACD
- OCCI -0.02
- HBIO -0.03
- Stochastic Oscillator
- OCCI 32.69
- HBIO 2.29
About OCCI OFS Credit Company Inc.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.